Drugs have the potential to cause a myriad of respiratory syndromes: here we consider specifically drug-induced cough. It is important to recognise that cough may be the initial manifestation of more serious drug-induced pulmonary syndromes such as interstitial lung disease, acute lung injury, pleural disease and pulmonary vascular disease caused by a number of well-recognised drugs (amiodarone, nitrofurantoin, methotrexate to name a few) which are not considered here. For more extensive reviews and an online drug database of pneumotoxicities which can be a useful reference of described toxicities if in doubt, see www.pneumotox.com.1,2 This short paper will consider the commonly used drugs that may be implicated in chronic cough.

ACE inhibitors

Angiotensin converting enzyme (ACE) inhibitors cause dry nocturnal cough in about 5–35% of people. Release of bradykinin, which is normally metabolised by ACE in the lungs, results in a typical tickling, scratchy or itchy sensation in the throat.3 There is a poor dose-response relationship and it normally occurs within the first week of treatment — but onset can sometimes be delayed for up to six months. In addition, although most cases subside after four weeks, a significant proportion of cases can take up to three months to resolve after stopping the drug.4 Although theophylline and cromoglycate have been advocated in the past to treat this cough, the only effective treatment is stopping the drug. It is more common in women (perhaps due to the heightened cough reflex in women) and also, interestingly, in Chinese people.5 Airflow obstruction is not usually a feature, and the presence of asthma does not change the likelihood of its occurrence.6 It is a class effect, and generally recurs if any other ACE inhibitor is reintroduced.

A2R blockers

Angiotensin 2 receptor (A2R) blockers are commonly used as a first substitute when ACE inhibitor cough appears, though they have a similar side effect profile to ACE inhibitors. However, cough can still occur with A2R blockers but is typically three to four times less common.7,8 Cough recurrence rates are also lower with A2R blockers but they should not be overlooked as a cause of chronic cough.

β-blockers

Cough may be the initial manifestation of drug-related airway hyper-responsiveness or bronchoconstriction that is described with β-blockers; associated wheeze and dyspnoea may occur. β-blockers (including eye drops) cause bronchoconstriction via bronchial β2 receptor blockade. A meta-analysis has confirmed no evidence of long-term decline in lung function in reversible obstructive lung disease with cardio-selective β-blockers (atenolol, metoprolol, bisoprolol). A short-term decline of 8% in forced expiratory volume in second (FEV1) was seen, but this was not sustained.9 In addition, long term respiratory symptoms and use of inhaled β-agonists were not increased. Carvedilol has also been shown to be well tolerated (in terms of lung function indices and aerobic performance) despite being a non-selective β-blocker, possibly because of mild bronchodilation from its α-blocking activity.10

NSAIDs

Aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, diclofenac, naproxen, and indomethacin, can cause bronchoconstriction in 5% of people with asthma by driving cysteinyl leukotriene production and inhibiting cyclooxygenase-1 (COX-1). Symptoms may occur within 30 minutes to 3 hours of ingestion and be associated with facial flushing and nasal and upper airway symptoms. Leukotriene antagonists (as part of asthma therapy) are particularly helpful in treating these symptoms.

Calcium antagonists

Calcium antagonists relax the lower oesophageal sphincter pressure and in dose-dependent fashion impair oesophageal clearance and cause reflux cough (amongst other symptoms). Reflux cough should be particularly suspected with cough on phonation, throat clearing, after meals, or cough on rising/stooping; it may also be the only manifestation of reflux (without dyspeptic symptoms).11 In studies of reflux-related symptoms, verapamil and amlodipine were reported as causing more reflux symptoms than diltiazem.12 Reflux cough may also be aggravated by other drugs including nitrates via similar effects on lower oesophageal sphincter pressure. Stopping the drug and avoiding other aggravating drugs may be the only intervention necessary. Resolution of symptoms may take up to 3 months.

Summary

  1. 1

    Consider the drug history carefully before investigating for other causes of cough; stopping the relevant drug is the key to treatment

  2. 2

    ACE inhibitor cough may not arise for 6 months and can take 3 months to subside on stopping the drug, and A2R blockers can also cause cough (although less commonly)

  3. 3

    β-blockers can be cautiously trialled in mild-moderate reversible obstructive lung disease. Cardio-selective β-blockers are preferable (atenolol, metoprolol) or combined α- and β-blockers (carvedilol)

  4. 4

    Consider occult asthma or bronchial hyper-reactivity with newonset cough following aspirin or NSAIDs.

  5. 5

    When reflux cough is suspected, don't forget calcium antagonists as a cause and nitrates.

  6. 6

    Drug-related cough may be the beginning of a more extensive syndrome and many drugs can cause such syndromes; consult Pneumotox database for quick assistance

Supplementary file 1